295 related articles for article (PubMed ID: 19816050)
21. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
22. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
Miyakoshi M; Kamoi K; Uchida S; Sasaki S
Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
24. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
Ding C; Beetz R; Rittner G; Bartsch O
Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
[TBL] [Abstract][Full Text] [Related]
25. A novel AVPR2 gene mutation of X-linked congenital nephrogenic diabetes insipidus in an Asian pedigree.
Guo WH; Li Q; Wei HY; Lu HY; Qu HQ; Zhu M
J Int Med Res; 2016 Oct; 44(5):1131-1137. PubMed ID: 27565746
[TBL] [Abstract][Full Text] [Related]
26. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
Devuyst O
Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
[TBL] [Abstract][Full Text] [Related]
27. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
Chen CH; Chen WY; Liu HL; Liu TT; Tsou AP; Lin CY; Chao T; Qi Y; Hsiao KJ
J Hum Genet; 2002; 47(2):66-73. PubMed ID: 11916004
[TBL] [Abstract][Full Text] [Related]
28. [Identification of mutations in the arginine vasopressin receptor 2 gene in congenital nephrogenic diabetes insipidus patients].
Gu F; Shi Y; Deng J; Jin Z
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1401-5. PubMed ID: 12509923
[TBL] [Abstract][Full Text] [Related]
29. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
[TBL] [Abstract][Full Text] [Related]
30. A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.
Zang L; Gong Y; Li Y; Dou J; Lyu Z; Su X; Zhang Y; Mu Y
Biomed Res Int; 2022; 2022():7073158. PubMed ID: 35865667
[TBL] [Abstract][Full Text] [Related]
31. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.
Ala Y; Morin D; Mouillac B; Sabatier N; Vargas R; Cotte N; Déchaux M; Antignac C; Arthus MF; Lonergan M; Turner MS; Balestre MN; Alonso G; Hibert M; Barberis C; Hendy GN; Bichet DG; Jard S
J Am Soc Nephrol; 1998 Oct; 9(10):1861-72. PubMed ID: 9773787
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
Rochdi MD; Vargas GA; Carpentier E; Oligny-Longpré G; Chen S; Kovoor A; Gitelman SE; Rosenthal SM; von Zastrow M; Bouvier M
Mol Pharmacol; 2010 May; 77(5):836-45. PubMed ID: 20159941
[TBL] [Abstract][Full Text] [Related]
33. Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus.
Kotnik P; Battelino T; Debeljak M; Podkrajsek KT; Waldhauser F; Frøkiaer J; Nielsen S; Krzisnik C
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):483-9. PubMed ID: 17550212
[TBL] [Abstract][Full Text] [Related]
34. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
Schöneberg T; Schulz A; Biebermann H; Grüters A; Grimm T; Hübschmann K; Filler G; Gudermann T; Schultz G
Hum Mutat; 1998; 12(3):196-205. PubMed ID: 9711877
[TBL] [Abstract][Full Text] [Related]
35. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.
Sadeghi H; Robertson GL; Bichet DG; Innamorati G; Birnbaumer M
Mol Endocrinol; 1997 Nov; 11(12):1806-13. PubMed ID: 9369448
[TBL] [Abstract][Full Text] [Related]
36. Intrafamilial phenotype variability in nephrogenic diabetes insipidus.
Kalenga K; Persu A; Goffin E; Lavenne-Pardonge E; van Cangh PJ; Bichet DG; Devuyst O
Am J Kidney Dis; 2002 Apr; 39(4):737-43. PubMed ID: 11920339
[TBL] [Abstract][Full Text] [Related]
37. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
[TBL] [Abstract][Full Text] [Related]
38. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
Robben JH; Sze M; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F253-60. PubMed ID: 16926443
[TBL] [Abstract][Full Text] [Related]
39. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family.
Yamashita S; Hata A; Usui T; Oda H; Hijikata A; Shirai T; Kaneko N; Hata D
J Pediatr Endocrinol Metab; 2016 May; 29(5):591-6. PubMed ID: 26974133
[TBL] [Abstract][Full Text] [Related]
40. A novel splicing mutation in the V2 vasopressin receptor.
Kamperis K; Siggaard C; Herlin T; Nathan E; Hertz JM; Rittig S
Pediatr Nephrol; 2000 Nov; 15(1-2):43-9. PubMed ID: 11095010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
